« New Module in the DeltaV Application Exchange | Main Index | Press Release: Emerson selected by leading mining and metals company to automate nickel recovery plant »

Innovative automation strategies for Asia's emerging biopharmaceutical manufacturing hub

Next Generation Pharmaceutical magazine reports Celltrion, a Korean-based biopharmaceutical manufacturer, forms a strategic partnership with Emerson, to achieve their operational excellence objectives.

By taking advantage of the PlantWeb architecture, DeltaV Batch software, and Emerson life sciences expertise, Celltrion and the project team saved 40 percent on the engineering and validation time. (334KB PDF)

Posted by Emerson's EasyDeltaV.com on July 22, 2005 |

Browse:

Go To EmersonProcess.com/DeltaV

PLEASE READ AND REVIEW THE FOLLOWING TERMS OF USE AGREEMENT CAREFULLY BEFORE USING THE RSS (REALLY SIMPLE SYNDICATION) WEBFEED. By subscribing to the DeltaV news webfeed and any other Emerson information provided by webfeed (collectively, the "Webfeed"), you agree to the following Terms of Use. If you do not agree, you may not subscribe to the Webfeed.

Terms of Use: You agree not to hold the Emerson Electric Co. or any of its subsidiaries and affiliates (collectively, "Emerson") responsible for any content provided by any third-party service. Emerson retains any ownership and other rights in the Webfeed. The Webfeed is Copyright 2005-2010 Emerson. All rights reserved. You shall attribute any proper use of the Webfeed. Emerson reserves the right to suspend or terminate this service at any time. The Webfeeds of this site are presented for promotional purposes only, and while every effort has been made to ensure their accuracy, they are not to be construed as warranties or guarantees, express or implied, regarding the products or services described herein or their use, availability or applicability. Not responsible for third-party content. Other Terms of Use